Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 119 entries
Sorted by: Best Match Show Resources per page
Nonthrombolytic therapy for acute myocardial infarction.

Heart & lung : the journal of critical care

Valle BK, Lemberg L.
PMID: 2777572
Heart Lung. 1989 Sep;18(5):535-7.

No abstract available.

Cite
Valle BK, Lemberg L. Nonthrombolytic therapy for acute myocardial infarction. Heart Lung. 1989;18(5):535-7
Valle, B. K., & Lemberg, L. (1989). Nonthrombolytic therapy for acute myocardial infarction. Heart & lung : the journal of critical care, 18(5), 535-7.
Valle, B K, and Lemberg, L. "Nonthrombolytic therapy for acute myocardial infarction." Heart & lung : the journal of critical care vol. 18,5 (1989): 535-7.
Valle BK, Lemberg L. Nonthrombolytic therapy for acute myocardial infarction. Heart Lung. 1989 Sep;18(5):535-7. PMID: 2777572.
Copy Download .nbib Format: NLM
Greater Beta-Adrenergic Receptor Mediated Vasodilation in Women Using Oral Contraceptives.

Frontiers in physiology

Limberg JK, Peltonen GL, Johansson RE, Harrell JW, Kellawan JM, Eldridge MW, Sebranek JJ, Walker BJ, Schrage WG.
PMID: 27375493
Front Physiol. 2016 Jun 08;7:215. doi: 10.3389/fphys.2016.00215. eCollection 2016.

BACKGROUND: β-adrenergic receptors play an important role in mitigating the pressor effects of sympathetic nervous system activity in young women. Based on recent data showing oral contraceptive use in women abolishes the relationship between muscle sympathetic nervous system activity...

Cite
Limberg JK, Peltonen GL, Johansson RE, et al. Greater Beta-Adrenergic Receptor Mediated Vasodilation in Women Using Oral Contraceptives. Front Physiol. 2016;7:215doi: 10.3389/fphys.2016.00215.
Limberg, J. K., Peltonen, G. L., Johansson, R. E., Harrell, J. W., Kellawan, J. M., Eldridge, M. W., Sebranek, J. J., Walker, B. J., & Schrage, W. G. (2016). Greater Beta-Adrenergic Receptor Mediated Vasodilation in Women Using Oral Contraceptives. Frontiers in physiology, 7215. https://doi.org/10.3389/fphys.2016.00215
Limberg, Jacqueline K, et al. "Greater Beta-Adrenergic Receptor Mediated Vasodilation in Women Using Oral Contraceptives." Frontiers in physiology vol. 7 (2016): 215. doi: https://doi.org/10.3389/fphys.2016.00215
Limberg JK, Peltonen GL, Johansson RE, Harrell JW, Kellawan JM, Eldridge MW, Sebranek JJ, Walker BJ, Schrage WG. Greater Beta-Adrenergic Receptor Mediated Vasodilation in Women Using Oral Contraceptives. Front Physiol. 2016 Jun 08;7:215. doi: 10.3389/fphys.2016.00215. eCollection 2016. PMID: 27375493; PMCID: PMC4896959.
Copy Download .nbib Format: NLM
[Number in tribute to Enrique Finochietto].

Prensa medica argentina

LEMBERG A.
PMID: 13465606
Prensa Med Argent. 1957 Mar 22;44(12):829-34.

No abstract available.

Cite
LEMBERG A. Numero en homenaje a Enrique Finochietto. [Number in tribute to Enrique Finochietto]. Prensa Med Argent. 1957;44(12):829-34
LEMBERG, A. (1957). Numero en homenaje a Enrique Finochietto. [Number in tribute to Enrique Finochietto]. Prensa medica argentina, 44(12), 829-34.
LEMBERG, A. "Numero en homenaje a Enrique Finochietto." [Number in tribute to Enrique Finochietto]. Prensa medica argentina vol. 44,12 (1957): 829-34.
LEMBERG A. Numero en homenaje a Enrique Finochietto. [Number in tribute to Enrique Finochietto]. Prensa Med Argent. 1957 Mar 22;44(12):829-34. Spanish. PMID: 13465606.
Copy Download .nbib Format: NLM
Coupled oxidation of ascorbic acid and haemoglobin: Formation and properties of choleglobin.

The Biochemical journal

Lemberg R, Legge JW, Lockwood WH.
PMID: 16747330
Biochem J. 1941 Mar;35(3):328-38. doi: 10.1042/bj0350328.

No abstract available.

Cite
Lemberg R, Legge JW, Lockwood WH. Coupled oxidation of ascorbic acid and haemoglobin: Formation and properties of choleglobin. Biochem J. 1941;35(3):328-38doi: 10.1042/bj0350328.
Lemberg, R., Legge, J. W., & Lockwood, W. H. (1941). Coupled oxidation of ascorbic acid and haemoglobin: Formation and properties of choleglobin. The Biochemical journal, 35(3), 328-38. https://doi.org/10.1042/bj0350328
Lemberg, R, et al. "Coupled oxidation of ascorbic acid and haemoglobin: Formation and properties of choleglobin." The Biochemical journal vol. 35,3 (1941): 328-38. doi: https://doi.org/10.1042/bj0350328
Lemberg R, Legge JW, Lockwood WH. Coupled oxidation of ascorbic acid and haemoglobin: Formation and properties of choleglobin. Biochem J. 1941 Mar;35(3):328-38. doi: 10.1042/bj0350328. PMID: 16747330; PMCID: PMC1265498.
Copy Download .nbib Format: NLM
Surgical intervention in children with Crohn's disease.

International journal of colorectal disease

Leonor R, Jacobson K, Pinsk V, Webber E, Lemberg DA.
PMID: 17530264
Int J Colorectal Dis. 2007 Sep;22(9):1037-41. doi: 10.1007/s00384-007-0281-3. Epub 2007 Feb 14.

INTRODUCTION: Crohn's disease (CD) causes chronic inflammation of the gastrointestinal tract leading to extensive medical treatments and surgery with two thirds of patients having surgery over their lifetime. In this study, we reviewed the pediatric population at the British...

Cite
Leonor R, Jacobson K, Pinsk V, et al. Surgical intervention in children with Crohn's disease. Int J Colorectal Dis. 2007;22(9):1037-41doi: 10.1007/s00384-007-0281-3.
Leonor, R., Jacobson, K., Pinsk, V., Webber, E., & Lemberg, D. A. (2007). Surgical intervention in children with Crohn's disease. International journal of colorectal disease, 22(9), 1037-41. https://doi.org/10.1007/s00384-007-0281-3
Leonor, R, et al. "Surgical intervention in children with Crohn's disease." International journal of colorectal disease vol. 22,9 (2007): 1037-41. doi: https://doi.org/10.1007/s00384-007-0281-3
Leonor R, Jacobson K, Pinsk V, Webber E, Lemberg DA. Surgical intervention in children with Crohn's disease. Int J Colorectal Dis. 2007 Sep;22(9):1037-41. doi: 10.1007/s00384-007-0281-3. Epub 2007 Feb 14. PMID: 17530264.
Copy Download .nbib Format: NLM
Predictors of quality of life of patients with type 2 diabetes.

Patient preference and adherence

Kalda R, Rätsep A, Lember M.
PMID: 19920940
Patient Prefer Adherence. 2008 Feb 02;2:21-6.

BACKGROUND: Researchers have shown that patients with type 2 diabetes have a lower quality of life than the general population and also somewhat lower than patients with other chronic diseases. Thus one of the most important outcomes of treatment...

Cite
Kalda R, Rätsep A, Lember M. Predictors of quality of life of patients with type 2 diabetes. Patient Prefer Adherence. 2008;2:21-6
Kalda, R., Rätsep, A., & Lember, M. (2008). Predictors of quality of life of patients with type 2 diabetes. Patient preference and adherence, 221-6.
Kalda, Ruth, et al. "Predictors of quality of life of patients with type 2 diabetes." Patient preference and adherence vol. 2 (2008): 21-6.
Kalda R, Rätsep A, Lember M. Predictors of quality of life of patients with type 2 diabetes. Patient Prefer Adherence. 2008 Feb 02;2:21-6. PMID: 19920940; PMCID: PMC2770386.
Copy Download .nbib Format: NLM
Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.

Arthritis research & therapy

Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, Ehl S.
PMID: 22682420
Arthritis Res Ther. 2012 Jun 08;14(3):213. doi: 10.1186/ar3843.

Hemophagocytic lymphohistiocytosis (HLH) is a rare life-threatening disease of severe hyperinflammation caused by uncontrolled proliferation of activated lymphocytes and macrophages secreting high amounts of inflammatory cytokines. It is a frequent manifestation in patients with predisposing genetic defects, but can...

Cite
Bode SF, Lehmberg K, Maul-Pavicic A, et al. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther. 2012;14(3):213doi: 10.1186/ar3843.
Bode, S. F., Lehmberg, K., Maul-Pavicic, A., Vraetz, T., Janka, G., Stadt, U. Z., & Ehl, S. (2012). Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis research & therapy, 14(3), 213. https://doi.org/10.1186/ar3843
Bode, Sebastian Fn, et al. "Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis." Arthritis research & therapy vol. 14,3 (2012): 213. doi: https://doi.org/10.1186/ar3843
Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, Ehl S. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther. 2012 Jun 08;14(3):213. doi: 10.1186/ar3843. PMID: 22682420; PMCID: PMC3446494.
Copy Download .nbib Format: NLM
Erratum to: The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study.

BMC musculoskeletal disorders

Jürisson M, Raag M, Kallikorm R, Lember M, Uusküla A.
PMID: 28836967
BMC Musculoskelet Disord. 2017 Aug 24;18(1):366. doi: 10.1186/s12891-017-1735-6.

No abstract available.

Cite
Jürisson M, Raag M, Kallikorm R, et al. Erratum to: The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study. BMC Musculoskelet Disord. 2017;18(1):366doi: 10.1186/s12891-017-1735-6.
Jürisson, M., Raag, M., Kallikorm, R., Lember, M., & Uusküla, A. (2017). Erratum to: The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study. BMC musculoskeletal disorders, 18(1), 366. https://doi.org/10.1186/s12891-017-1735-6
Jürisson, Mikk, et al. "Erratum to: The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study." BMC musculoskeletal disorders vol. 18,1 (2017): 366. doi: https://doi.org/10.1186/s12891-017-1735-6
Jürisson M, Raag M, Kallikorm R, Lember M, Uusküla A. Erratum to: The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study. BMC Musculoskelet Disord. 2017 Aug 24;18(1):366. doi: 10.1186/s12891-017-1735-6. PMID: 28836967; PMCID: PMC5571483.
Copy Download .nbib Format: NLM
Hip and Knee Section, Treatment, Two-Stage Exchange Spacer-Related: Proceedings of International Consensus on Orthopedic Infections.

The Journal of arthroplasty

Abdel MP, Barreira P, Battenberg A, Berry DJ, Blevins K, Font-Vizcarra L, Frommelt L, Goswami K, Greiner J, Janz V, Kendoff DO, Limberg AK, Manrique J, Moretti B, Murylev V, O'Byrne J, Petrie MJ, Porteous A, Saleri S, Sandiford NA, Sharma V, Shubnyakov I, Sporer S, Squire MW, Stockley I, Tibbo ME, Turgeon T, Varshneya A, Wellman S, Zahar A.
PMID: 30348562
J Arthroplasty. 2019 Feb;34(2):S427-S438. doi: 10.1016/j.arth.2018.09.027. Epub 2018 Oct 19.

No abstract available.

Cite
Abdel MP, Barreira P, Battenberg A, et al. Hip and Knee Section, Treatment, Two-Stage Exchange Spacer-Related: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty. 2018;34(2):S427-S438doi: 10.1016/j.arth.2018.09.027.
Abdel, M. P., Barreira, P., Battenberg, A., Berry, D. J., Blevins, K., Font-Vizcarra, L., Frommelt, L., Goswami, K., Greiner, J., Janz, V., Kendoff, D. O., Limberg, A. K., Manrique, J., Moretti, B., Murylev, V., O'Byrne, J., Petrie, M. J., Porteous, A., Saleri, S., Sandiford, N. A., Sharma, V., Shubnyakov, I., Sporer, S., Squire, M. W., Stockley, I., Tibbo, M. E., Turgeon, T., Varshneya, A., Wellman, S., & Zahar, A. (2019). Hip and Knee Section, Treatment, Two-Stage Exchange Spacer-Related: Proceedings of International Consensus on Orthopedic Infections. The Journal of arthroplasty, 34(2), S427-S438. https://doi.org/10.1016/j.arth.2018.09.027
Abdel, Matthew P, et al. "Hip and Knee Section, Treatment, Two-Stage Exchange Spacer-Related: Proceedings of International Consensus on Orthopedic Infections." The Journal of arthroplasty vol. 34,2 (2019): S427-S438. doi: https://doi.org/10.1016/j.arth.2018.09.027
Abdel MP, Barreira P, Battenberg A, Berry DJ, Blevins K, Font-Vizcarra L, Frommelt L, Goswami K, Greiner J, Janz V, Kendoff DO, Limberg AK, Manrique J, Moretti B, Murylev V, O'Byrne J, Petrie MJ, Porteous A, Saleri S, Sandiford NA, Sharma V, Shubnyakov I, Sporer S, Squire MW, Stockley I, Tibbo ME, Turgeon T, Varshneya A, Wellman S, Zahar A. Hip and Knee Section, Treatment, Two-Stage Exchange Spacer-Related: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty. 2019 Feb;34(2):S427-S438. doi: 10.1016/j.arth.2018.09.027. Epub 2018 Oct 19. PMID: 30348562.
Copy Download .nbib Format: NLM
Localization regime in diffusion NMR: Theory and experiments.

Journal of magnetic resonance (San Diego, Calif. : 1997)

Moutal N, Demberg K, Grebenkov DS, Kuder TA.
PMID: 31295631
J Magn Reson. 2019 Aug;305:162-174. doi: 10.1016/j.jmr.2019.06.016. Epub 2019 Jul 02.

In this work we investigate the emergence of the localization regime for diffusion NMR in various geometries: inside slabs, inside cylinders and outside rods arranged on a square array. At high gradients, the transverse magnetization is strongly attenuated in...

Cite
Moutal N, Demberg K, Grebenkov DS, et al. Localization regime in diffusion NMR: Theory and experiments. J Magn Reson. 2019;305:162-174doi: 10.1016/j.jmr.2019.06.016.
Moutal, N., Demberg, K., Grebenkov, D. S., & Kuder, T. A. (2019). Localization regime in diffusion NMR: Theory and experiments. Journal of magnetic resonance (San Diego, Calif. : 1997), 305162-174. https://doi.org/10.1016/j.jmr.2019.06.016
Moutal, Nicolas, et al. "Localization regime in diffusion NMR: Theory and experiments." Journal of magnetic resonance (San Diego, Calif. : 1997) vol. 305 (2019): 162-174. doi: https://doi.org/10.1016/j.jmr.2019.06.016
Moutal N, Demberg K, Grebenkov DS, Kuder TA. Localization regime in diffusion NMR: Theory and experiments. J Magn Reson. 2019 Aug;305:162-174. doi: 10.1016/j.jmr.2019.06.016. Epub 2019 Jul 02. PMID: 31295631.
Copy Download .nbib Format: NLM
Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients.

Scandinavian journal of pain

Lemberg KK, Heiskanen TE, Neuvonen M, Kontinen VK, Neuvonen PJ, Dahl ML, Kalso EA.
PMID: 29913934
Scand J Pain. 2010 Jan 01;1(1):24-33. doi: 10.1016/j.sjpain.2009.09.003.

Oxycodone is a strong opioid and it is increasingly used in the management of acute and chronic pain. The pharmacodynamic effects of oxycodone are mainly mediated by the μ-opioid receptor. However, its affinity for the μ-opioid receptor is significantly...

Cite
Lemberg KK, Heiskanen TE, Neuvonen M, et al. Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients. Scand J Pain. 2010;1(1):24-33doi: 10.1016/j.sjpain.2009.09.003.
Lemberg, K. K., Heiskanen, T. E., Neuvonen, M., Kontinen, V. K., Neuvonen, P. J., Dahl, M. L., & Kalso, E. A. (2010). Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients. Scandinavian journal of pain, 1(1), 24-33. https://doi.org/10.1016/j.sjpain.2009.09.003
Lemberg, K K, et al. "Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients." Scandinavian journal of pain vol. 1,1 (2010): 24-33. doi: https://doi.org/10.1016/j.sjpain.2009.09.003
Lemberg KK, Heiskanen TE, Neuvonen M, Kontinen VK, Neuvonen PJ, Dahl ML, Kalso EA. Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients. Scand J Pain. 2010 Jan 01;1(1):24-33. doi: 10.1016/j.sjpain.2009.09.003. PMID: 29913934.
Copy Download .nbib Format: NLM
Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement.

Current drug metabolism

Alt J, Gori SS, Lemberg KM, Pal A, Veeravalli V, Wu Y, Aguilar JMH, Dash RP, Tenora L, Majer P, Sun Q, Slusher BS, Rais R.
PMID: 34488583
Curr Drug Metab. 2021;22(9):735-745. doi: 10.2174/1389200222666210831125041.

BACKGROUND: Metabolomic analyses from our group and others have shown that tumors treated with glutamine antagonists (GA) exhibit robust accumulation of formylglycinamide ribonucleotide (FGAR), an intermediate in the de novo purine synthesis pathway. The increase in FGAR is attributed...

Cite
Alt J, Gori SS, Lemberg KM, et al. Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement. Curr Drug Metab. 2021;22(9):735-745doi: 10.2174/1389200222666210831125041.
Alt, J., Gori, S. S., Lemberg, K. M., Pal, A., Veeravalli, V., Wu, Y., Aguilar, J. M. H., Dash, R. P., Tenora, L., Majer, P., Sun, Q., Slusher, B. S., & Rais, R. (2021). Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement. Current drug metabolism, 22(9), 735-745. https://doi.org/10.2174/1389200222666210831125041
Alt, Jesse, et al. "Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement." Current drug metabolism vol. 22,9 (2021): 735-745. doi: https://doi.org/10.2174/1389200222666210831125041
Alt J, Gori SS, Lemberg KM, Pal A, Veeravalli V, Wu Y, Aguilar JMH, Dash RP, Tenora L, Majer P, Sun Q, Slusher BS, Rais R. Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement. Curr Drug Metab. 2021;22(9):735-745. doi: 10.2174/1389200222666210831125041. PMID: 34488583; PMCID: PMC8684803.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 119 entries